Pfizer Inc. (PFE)
25.68
+0.06
(+0.23%)
USD |
NYSE |
Jun 09, 16:00
25.73
+0.05
(+0.19%)
After-Hours: 17:36
Pfizer SG&A Expense (Quarterly) : 2.961B for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Johnson & Johnson | 6.034B |
| Eli Lilly & Co. | 2.934B |
| Merck & Co., Inc. | 2.70B |
| Viatris, Inc. | 928.80M |
| Bristol Myers Squibb Co. | 1.617B |